Funder
Novartis Pharmaceuticals Corporation
Publisher
Springer Science and Business Media LLC
Reference155 articles.
1. Kihara Y, Maceyka M, Spiegel S, Chun J. Lysophospholipid receptor nomenclature review: IUPHAR review 8. Br J Pharmacol. 2014;171(15):3575–94. https://doi.org/10.1111/bph.12678.
2. Mutoh T, Rivera R, Chun J. Insights into the pharmacological relevance of lysophospholipid receptors. Br J Pharmacol. 2012;165(4):829–44. https://doi.org/10.1111/j.1476-5381.2011.01622.x.
3. Kihara Y, Misuno H, Chun J. Lysophospholipid receptors in drug discovery. Exp Cell Res. 2015;333(2):171–7. https://doi.org/10.1016/j.yexcr.2014.11.020.
4. Kunkel GT, Maceyka M, Milstien S, Spiegel S. Targeting the sphingosine-1-phosphate axis in cancer, inflammation and beyond. Nat Rev Drug Discov. 2013;12(9):688–702. https://doi.org/10.1038/nrd4099.
5. Novartis Pharmaceuticals Corporation. Mayzent®—prescribing information (2019). https://www.pharma.us.novartis.com/sites/www.pharma.us.novartis.com/files/mayzent.pdf. Accessed 19 Sept 2019.
Cited by
109 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献